The Latest Analyst Ratings For Legend Biotech
The Latest Analyst Ratings For Legend Biotech
傳奇生物的最新分析師評級
In examining recent analyst actions, we gain insights into how...In the preceding three months, 15 analysts have released ratings for Legend Biotech (NASDAQ:LEGN), presenting a wide array of perspectives from bullish to bearish.
在過去三個月中，共有15名分析師發佈了關於傳奇生物（納斯達克股票代碼爲LEGN）的評級，提供了從看好到看淡的廣泛觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $78.93, a high estimate of $90.00, and a low estimate of $60.00. Highlighting a 2.56% decrease, the current average has fallen from the previous average price target of $81.00.
分析師所分析的12個月股價目標提供了洞察力，平均目標爲78.93美元，高估值爲90.00美元，低估值爲60.00美元。當前平均值降低2.56%，從之前的81.00美元的平均股價目標下降。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
In examining recent analyst actions, we gain insights into how...
通過分析最近的分析師...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間